Both saw heavy trading a day after their
results, with Salix plummeting and Zynga advancing.
Salix sank 37 percent to $87.50, on track for its biggest
one-day drop in its history. Volume was about 250,000 shares.
The stock has been under heavy pressure, with Friday set to be
its sixth straight day of declines. The drop will wipe out much
of the stock's gains for the year. Based on its Thursday closing
price, the stock is up 54 percent in 2014.
The biotech company slashed its full-year forecast in results
released late Thursday and said inventory for its key drugs had
piled up. Sources familiar with the matter told Reuters that the
inventory issue dissuaded Allergan Inc <AGN.N> from acquiring
the drugmaker.
On the upside, Zynga reported better-than-expected third-quarter
results as it set its mobile gaming push in motion with releases
such as "New Words with Friends."
The stock, which has lost almost 40 percent so far this year,
rose 10 percent to $2.60 before the bell, on track for its
biggest one-day jump since Jan. 31.
In the broader market, U.S. stock index futures were little
changed on Friday, as investors held off bets ahead of a key
jobs report that could indicate whether the market's record
levels are justified by the economy's fundamentals.
Futures snapshot at 7:41 a.m.:
* S&P 500 e-minis <ESc1> were down 0.5 point, or 0.02 percent,
with 127,938 contracts changing hands.
* Nasdaq 100 e-minis <NQc1> were up 4.75 points, or 0.11
percent, in volume of 21,185 contracts.
* Dow e-minis <1YMc1> were up 1 point, or 0.01 percent, with
21,838 contracts changing hands.
(Editing by Bernadette Baum)
[© 2014 Thomson Reuters. All rights
reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|
|